Healthcare ‘Power 25’ published
Included are colleagues from many BioCT member companies: AI Therapeutics BioXcel Therapeutics Trevi Therapeutics Arvinas Biohaven Pharmaceuticals Bioasis Azitra Alexion (AstraZeneca Rare Disease) Yale more
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Included are colleagues from many BioCT member companies: AI Therapeutics BioXcel Therapeutics Trevi Therapeutics Arvinas Biohaven Pharmaceuticals Bioasis Azitra Alexion (AstraZeneca Rare Disease) Yale more
View this email in your browser Career News – June 21, 2022 2022 STEM Networking Event Date: September 20, 2022 Time: 4:00 – 7:00 PM...
Mystic-based agritech firm Enko will tap into DNA-encoded libraries and drug-discovery technology to help it develop new ways to protect crops … more Enko has opened new headquarters...
New Haven has the country’s 20th best life science workforce base, according to a recent report. CBRE Group, the Dallas-based commercial real estate services and...
Astrocyte Pharmaceuticals has begun its first-in-human Phase 1 clinical study with the dosing of a first subject with AST-004, a promising investigational therapeutic being advanced as a...
View this email in your browser Weekly Roundup – June 16, 2022 We are at the BIO International Convention! Thank you to our sponsors and all...
Formed from the Governor’s Workforce Council and working in collaboration with the Greater New Haven Chamber of Commerce, SPRINT (Student Program to Ready Interns for Next-generation Talent)...
In an op-ed, Paul Pescatello, chairman of We Work for Health Connecticut, writes: Lately, stakeholders in the health economy have been playing the “blame game” over...
Arvinas is calling for entries for their inaugural Early Career Research Award, which will recognize the efforts of up-and-coming researchers bringing innovation, new approaches and creative...
Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBAs and MDs interested in forming new...